Wax moth larva (Galleria mellonella): An in vivo model for assessing the efficacy of antistaphylococcal agents

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 8, 2011, Pages 1785-1790

  Desbois, Andrew P ^a   Coote, Peter J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Antibacterial; Antimicrobial; Daptomycin; Drug discovery; Drug resistance; Insect infection model; MRSA; Staphylococcus aureus; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CELL CULTURE; CELL FREE SYSTEM; DRUG EFFICACY; GALLERIA MELLONELLA; HOST; IN VIVO STUDY; INCUBATION TEMPERATURE; INOCULATION; LARVA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; MOTH; NONHUMAN; REPEATED DRUG DOSE; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; LARVA; MOTHS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79960442678     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr198     Document Type: Article

References (29)

1. Resch A, Wilke M, Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 2009; 10: 287-97.
2. Weigelt JA, Lipsky BA, Tabak YP et al. Surgical site infections: causative pathogens and associated outcomes. Am J Infect Control 2010; 38: 112-20.
3. Marty FM, Yeh WW, Wennersten CB et al. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 2006; 44: 595-7.
4. Simor AE, Stuart TL, Louie L et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007; 51: 3880-6.
5. Abbanat D, Morrow B, Bush K. New agents in development for the treatment of bacterial infections. Curr Opin Pharmacol 2008; 8: 582-92.
6. Desbois AP, Mearns-Spragg A, Smith VJ. A fatty acid from the diatom Phaeodactylum tricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcus aureus (MRSA). Mar Biotechnol 2009; 11: 45-52.
7. Desbois AP, Gemmell CG, Coote PJ. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 2010; 35: 559-65.
8. Falcone M, Serra P, Venditti M. Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians. Eur J Int Med 2009; 20: 343-7.
9. Kaito C, Akimitsu N, Watanabe H et al. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog 2002; 32: 183-90.
10. Garci{dotless}́a-Lara J, Needham AJ, Foster SJ. Invertebrates as animal models for Staphylococcus aureus pathogenesis: a window into host-pathogen interaction. FEMS Immunol Med Microbiol 2005; 43: 311-23.
11. Seabra R, Bhogal N. Hospital infections, animal models and alternatives. Eur J Clin Microb Infect Dis 2009; 28: 561-8.
12. Wu K, Conly J, McClure J-A et al. Caenorhabditis elegans as a host model for community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2010; 16: 245-54.
13. Champion OL, Cooper IAM, James SL et al. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology 2009; 155: 1516-22.
14. Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 2000; 182: 3843-5.
15. Mukherjee K, Altincicek B, Hain T et al. Galleria mellonella as a model system for studying Listeria pathogenesis. Appl Environ Microbiol 2010; 76: 310-7.
16. Peleg AY, Monga D, Pillai S et al. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 2006; 199: 532-6.
17. Peleg AY, Jara S, Monga D et al. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53: 2605-9.
18. Seed KD, Dennis JJ. Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun 2008; 76: 1267-75.
19. Gao W, Chua K, Davies JK et al. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 2010; 6: e1000944.
20. Purves J, Cockayne A, Moody PCE et al. Comparison of the regulation, metabolic function and role in virulence of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) homologues gapA and gapB in Staphylococcus aureus. Infect Immun 2010; 78: 5223-32.
21. Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microb Rev 2004; 28: 101-12.
22. Konkel ME, Tilly K. Temperature-regulated expression of bacterial virulence genes. Microbes Infect 2000; 2: 157-66.
23. Mylonakis E, Moreno R, El Khoury JB et al. Galleria mellonella as a model system to study Crytococcus neoformans pathogenesis. Infect Immun 2005; 73: 3842-50.
24. Rowan R, Moran C, McCann M et al. Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. Biometals 2009; 22: 461-7.
25. Coughlan A, Scanlon K, Mahon BP et al. Zinc and silver glass polyalkenoate cements: an evaluation of their antibacterial nature. Biomed Mater Eng 2010; 20: 99-106.
26. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2008.
27. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
28. Joint Formulary Committee. British National Formulary, 56th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2008.
29. Ohlsen K, Koller K-P, Hacker J. Analysis of expression of the alphatoxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun 1997; 65: 3606-14.